Active Pharmaceutical Ingredients Market Size, Share, And Growth Rate Analysis 2023
The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032
The Business Research Company’s active pharmaceutical ingredients market report forecasts the active pharmaceutical ingredients market size to grow to $275.36 Billion by 2027, with a CAGR (compound annual growth rate) of 6%.
Learn More On The Active Pharmaceutical Ingredients Market Report 2023 – https://www.thebusinessresearchcompany.com/report/active-pharmaceutical-ingredients-global-market-report
Active Pharmaceutical Ingredients Market Size Forecast
The global active pharmaceutical ingredients market is expected to grow from $204.11 billion in 2022 to $218.40 billion in 2023 at a compound annual growth rate (CAGR) of 7.0%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The active pharmaceutical ingredients market size is expected to grow to $275.36 billion in 2027 at a CAGR of 6.0%.
North America held the largest active pharmaceutical ingredients market share.
Key Active Pharmaceutical Ingredients Market Driver – Increase In The Incidence Of Chronic Diseases
For instance, according to IDF Diabetes Atlas published by the International Diabetes Federation (IDF), a Belgium-based global organization to advocate for the global treatment, control, and cure of diabetes, by 2030, the number of people with diabetes is expected to increase to 578 million, and 700 million by 2045 from 463 million in 2019. Nearly half of deaths from diabetes occur in adults under the age of 60, making it one of the top 10 killers. Therefore, increasing incidence of chronic diseases will drive the growth of the active pharmaceutical ingredients market.
Request for A Sample Of The Global Active Pharmaceutical Ingredients Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8539&type=smp
Key Active Pharmaceutical Ingredients Market Trend – Technological Advancement In API Manufacturing
Major companies operating in the market are focusing on implementing innovative technologies and methods in the optimized production of APIs such as continuous flow chemistry, advancements in lyophilization, powder handling, and process control to sustain their position in the market. For instance, in May 2022, the companies such as NovAliX, a France-based clinical research organization focused on drug discovery, ALYSOPHIL SAS, a France-based developer of an innovative industrial strategy based on continuous flow chemistry, De Dietrich Process Systems, a France-based global provider of engineered systems, process solutions, and process equipment and Bruker, a US-based developer, producer, and seller of high-performance scientific equipment as well as analytical and diagnostic solutions have partnered to introduce an innovative method for producing active pharmaceutical ingredients (APIs). The PIPAc (Production Intelligente de Principes Actifs) project, which is based on a Smart Production of Active Ingredients model, aims to advance API manufacturing by severing the lengthy and frequently complex supply chains connected with pharmaceutical production and developing rapid-response mobile API production units that are prepared for global deployment. PIPAc will develop next-generation, autonomous, and optimized unit by fusing cutting-edge synthesis, continuous flow chemistry, and in-flow analysis with artificial intelligence.
Active Pharmaceutical Ingredients Market Segment
1) By Type: Innovative APIs (Active Pharmaceutical Ingredient), Generic APIs (Active Pharmaceutical Ingredient)
2) By Type Of Manufacturer: Captive Manufacturers, Merchant Manufacturers
3) By Type Of Synthesis: Synthetic APIs (Active Pharmaceutical Ingredient), Biotech APIs (Active Pharmaceutical Ingredient)
4) By Type Of Drug: Prescription Drugs, Over-The-Counter Drugs
5) By Therapeutic Application: Communicable Diseases, Oncology, Diabetes, Cardiovascular Disease, Pain Management, Respiratory Diseases, Other Therapeutic Applications
Active Pharmaceutical Ingredients Market Major Players and Strategies
Major players in the active pharmaceutical ingredients market are Albemarle Corporation, Aurobindo Pharma, Dr. Reddy’s Laboratories Ltd., AbbVie Inc., Teva Pharmaceutical Industries Ltd., Cipla Inc., Boehringer Ingelheim International GmbH, Merck KGaA, Sun Pharmaceutical Industries Ltd., Bristol-Myers Squibb Company, Mylan Pharmaceuticals ULC, BASF Corporation, Lupin, Johnson & Johnson Services Inc., and F. Hoffmann-La Roche Ltd.
In June 2021, Aceto, a US-based supplier of specialty materials for the health sciences and high-tech end markets acquired Cascade Chemistry for an undisclosed amount. With this acquisition, Aceto expects to provide its clients better support throughout the drug development process and easier access to expanded North American manufacturing, especially for APIs and advanced intermediates. Cascade Chemistry is a US-based contract development and manufacturing organization (CDMO) and a manufacturer of active pharmaceutical ingredients.
The Active Pharmaceutical Ingredients Global Market Report 2023 covers regional data on active pharmaceutical ingredients market size, active pharmaceutical ingredients market trends and drivers, opportunities, strategies, and active pharmaceutical ingredients market competitor analysis. The countries covered in the active pharmaceutical ingredients market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.
The active pharmaceutical ingredient (API) is any component or substance used in a finished pharmaceutical product (FPP) and is designed to have pharmacological action or otherwise have a direct impact on the treatment, mitigation, cure, or prevention of disease. It is also used for the restoration, correction, or modification of human physiological processes.
View More Reports Related To The Active Pharmaceutical Ingredients Market –
Pharmaceutical API Manufacturing Global Market Report 2023
Pharmaceutical Contract Development And Manufacturing Organization (CMO) Global Market Report 2023
Veterinary Active Pharmaceutical Ingredients Manufacturing Global Market Report 2023
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: